Business Context and Reporting Period
Lantheus Holdings, Inc. filed this Form 8-K on September 2, 2016, to report a material definitive agreement entered into by its operating subsidiary, Lantheus Medical Imaging, Inc.
Key Financial Metrics
This filing does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity metrics. The report focuses exclusively on a contractual amendment.
Material Changes
On September 2, 2016, the Company entered into a Second Amendment to its Manufacturing and Supply Agreement (MSA) with Jubilant HollisterSteir LLC (JHS) regarding the manufacture of DEFINITY®. Key changes include:
- Supply Commitment: JHS is now obligated to supply all of the Company's DEFINITY® requirements through July 31, 2018.
- Contract Term: The agreement extends the manufacturing relationship through January 2022.
- Pricing: The amendment includes incremental pricing adjustments through the end of the contract term in exchange for the supply commitment.
Guidance, Outlook, and Risks
The filing does not contain updated financial guidance, management commentary on future performance, or a discussion of general risks. The primary contingency noted is the execution of the amended agreement, with the full text expected to be filed as an exhibit to the Quarterly Report on Form 10-Q for the quarter ending September 30, 2016.
Investor Verification Checklist
- Verify the specific incremental pricing terms in the full text of the Second Amendment.
- Confirm the impact of the extended supply commitment on future cost of goods sold.
- Review the upcoming Form 10-Q for the full exhibit of the Amendment.